JPH107518A - Skin lotion - Google Patents

Skin lotion

Info

Publication number
JPH107518A
JPH107518A JP8164196A JP16419696A JPH107518A JP H107518 A JPH107518 A JP H107518A JP 8164196 A JP8164196 A JP 8164196A JP 16419696 A JP16419696 A JP 16419696A JP H107518 A JPH107518 A JP H107518A
Authority
JP
Japan
Prior art keywords
skin
extract
plant
family
seeds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8164196A
Other languages
Japanese (ja)
Inventor
Koichi Matsumoto
宏一 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ikeda Corp
Original Assignee
Ikeda Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikeda Bussan Co Ltd filed Critical Ikeda Bussan Co Ltd
Priority to JP8164196A priority Critical patent/JPH107518A/en
Publication of JPH107518A publication Critical patent/JPH107518A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a skin lotion having an effect comparable to or exceeding an extract derived from an animal by containing an extract of seeds of a family Leguminosae plant and an extract of a family Lamiacea plant. SOLUTION: This skin lotion contains an extract from seeds of Lupinus albus L. as a family Leguminosae plant and an extract from Thymus vulgaris L. as a family Lamiacea plant as active components. The preparation contains 0.1-50wt.% in total amount of both extracts and is prepared to creamy, an ointmentlike, a milky lotion-like, a gel-like, filmy or a liquid-like. A highly polymerized protein contained in the Lupinus albus L. exhibits a tightening effect for skin and makes the surface of skin smooth by forming a film on the skin. Flavonoid or tannin contained in the Thymus vulgaris L. promotes hydroxylation of proline or lysine important in transforming procollagen to collagen and assists reconstruction of a tissue by an anti-elastin action. Therefore, the preparation exhibits a tightening effect for skin, reducing depth of wrinkle on the skin and further reducing microscopic undulations on the skin, then smoothing the skin.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は皮膚外用剤に係り、
殊に豆科植物の種子及びシソ科植物の抽出物を主たる有
効成分としている皮膚外用剤に係る。
TECHNICAL FIELD The present invention relates to an external preparation for skin,
Particularly, the present invention relates to an external preparation for skin containing a legume plant seed and a Labiatae plant extract as main active ingredients.

【0002】[0002]

【従来の技術】皮膚に対する生理活性を期待して、皮膚
外用剤中に天然抽出物を配合しようとする試みは古くか
らなされている。このような目的で使用される天然素材
は、主として動物の臓器 (脳、肝臓、脾臓等) 及び体液
(血液等) 並びに植物の組織 (葉、茎、根、花、種子
等) である。
2. Description of the Related Art There have long been attempts to incorporate a natural extract into an external preparation for skin with an expectation of physiological activity on the skin. Natural materials used for such purposes are mainly animal organs (brain, liver, spleen, etc.) and body fluids
(Blood, etc.) and plant tissues (leaves, stems, roots, flowers, seeds, etc.).

【0003】これら天然素材からの抽出物に含有されて
いる生理活性成分としては、各種の燐脂質、ビタミン
類、アミノ酸類、蛋白質、アルブチン、コウジ酸、胎盤
エキス、血清アルブミン (例えば牛血清アルブミン)、
グリコサミノグリカン、ヒアルロン酸、コラーゲン、エ
ラスチン、ポリフェノール (例えばタンニン)、フラボ
ノイド等が知られている。
[0003] The physiologically active components contained in the extracts from these natural materials include various phospholipids, vitamins, amino acids, proteins, arbutin, kojic acid, placenta extract, and serum albumin (for example, bovine serum albumin). ,
Glycosaminoglycans, hyaluronic acid, collagen, elastin, polyphenols (for example, tannins), flavonoids and the like are known.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、これら
の抽出物は乾燥保存素材を温又は熱水或いは各種の有機
溶剤にて処理することにより或る種の成分を溶出させ、
濾過し、場合により分画処理等を施して得られたものが
大部分であり、一部のものを除けば生理活性物質の含有
量が低い。又、有効成分の本質が特定されているものも
少なく、その効果について実証されているものは限られ
ているのが実状である。
However, these extracts elute certain components by treating the dry-preserved material with warm or hot water or various organic solvents.
Most of them are obtained by filtration and optionally fractionation, and the content of the physiologically active substance is low except for a part. In many cases, the essence of the active ingredient is not specified, and the fact that the effect is proven is limited.

【0005】更に、近年においては動物愛護等の観点か
ら動物起源の抽出物を植物起源のものに転換しようとす
る気運が高まっている。しかしながら、動物の臓器等か
らの抽出物は生理活性が高いものが多く、従って植物起
源のものであり且つ効果が動物起源のものに匹敵乃至凌
駕する抽出物を見い出すことは容易なことではない。
尚、仮に有用な生理活性を示す成分を含有している植物
資源があったとしても、上記のような一般的な抽出方法
では有用成分に変質を生じさせる場合がある。
[0005] In recent years, there has been a growing trend to convert animal-derived extracts to plant-derived extracts from the viewpoint of animal welfare and the like. However, extracts from animal organs and the like often have high bioactivity, and it is not easy to find an extract that is of plant origin and has an effect comparable to or superior to that of animal origin.
Even if there is a plant resource containing a component exhibiting a useful physiological activity, the useful component may be deteriorated by the above-mentioned general extraction method.

【0006】[0006]

【課題を解決するための手段】処で、シロバナルーピン
(Lupinus albus L.) はハウチマメ属に分類される一年
生の豆科植物であり、南部及び中部ヨーロッパにおいて
は 3000 年以上前から栽培され、種子は食用に、茎や葉
は飼料用に供されている。種子は水分 11.0%、蛋白質 3
2.8%、脂肪 8.9%、無窒素抽出物 44.7%、糖分 6.3% 及
び灰分 2.6%を含有している旨の報告がある。更に、シ
ロバナルーピンの種子にはアルブミンやグロブリン等の
高分子量の貯蔵蛋白質が多く含まれている。一方、タチ
ジャコウソウ [「タイム」とも称される (Thymus vulga
ris L.)]はイブキジャコウソウ属に分類される多年生の
シソ科植物であって、株立ち性の小低木である。この植
物は地中海沿岸地域を中心に古くからヨーロッパで知ら
れている代表的なハーブであり花、若茎及び葉には強い
芳香があり、フラボノイドやタンニンに富んでいる。
[Means for Solving the Problems] At this point, a white banana lupine
( Lupinus albus L.) is an annual legume that is classified in the genus Haupa, and has been cultivated in southern and central Europe for more than 3000 years, with seeds used for food and stems and leaves used for feed. I have. Seeds 11.0% moisture, protein 3
It is reported to contain 2.8%, fat 8.9%, nitrogen-free extract 44.7%, sugar 6.3% and ash 2.6%. Furthermore, the seeds of white lupine contain a large amount of high-molecular-weight storage proteins such as albumin and globulin. On the other hand, Thymus vulga [ Thymus vulga
ris L.)] is a perennial Lamiaceae plant classified in the genus Ibukija, and is a standing shrub. This plant is a typical herb known from Europe for a long time mainly in the Mediterranean coastal region, and has a strong aroma in flowers, shoots and leaves, and is rich in flavonoids and tannins.

【0007】本発明者は、シロバナルーピンの種子は高
分子量の蛋白質及び含硫アミノ酸等の、又タチジャコウ
ソウはフラボノイドやタンニン等の有用な生理活性成分
を多く含有している事実に着目し、これらからの抽出物
を皮膚外用剤の有効成分として利用するために鋭意検討
を行った。即ち、上記の抽出物が皮膚に及ぼす影響を調
べた処、シロバナルーピンに含まれる高分子量の蛋白質
は優れた肌引き締め効果を示し、同時に皮膚上で一種の
膜を形成する能力を有していることが判明した。このよ
うにして形成された弾力性のある膜により皮膚表面はよ
り滑らかになること、及びタチジャコウソウに含まれる
フラボノイドやタンニンはプロコラーゲンをコラーゲン
に変換する際に重要な役割を演じているプロリンやリジ
ンの水酸化を促進し、抗エラスチン作用により組織の再
構築を助成することが判明し、本発明の端緒を得た。
The inventors of the present invention have paid attention to the fact that the seeds of Shirovana lupine contain a large amount of useful bioactive components such as high-molecular-weight proteins and sulfur-containing amino acids, and the falcon scutellaria contains many useful bioactive components such as flavonoids and tannins. Investigations were made to use the extract from Escherichia coli as an active ingredient of an external preparation for skin. That is, when the effect of the above extract on the skin was examined, the high-molecular-weight protein contained in Shirovana lupine exhibited an excellent skin tightening effect, and at the same time, had the ability to form a kind of film on the skin. It has been found. The resilient membrane formed in this way makes the skin surface smoother, and the flavonoids and tannins contained in T. chinensis play an important role in converting procollagen to collagen. It has been found that it promotes lysine hydroxylation and promotes tissue remodeling by anti-elastin action, thus providing the beginning of the present invention.

【0008】そこで、上記の抽出混合物を含む水溶液及
びクリームを調製し、健常人ボランティアを用いて各種
の試験を行い、皮膚に及ぼす上記抽出混合物の効果を検
討した。その結果、全てのボランティアが牛血清アルブ
ミン (BSA) 含有水溶液よりも本抽出物含有水溶液の皮
膚引き締め効果が優れていると回答した。又、塗布前後
の皮膚レプリカを作製して走査型電子顕微鏡を用いて皮
膚表面を解析したところ、本願発明のクリーム剤は、塗
布前と比較して皺の深さが減少し、より滑らかな外見を
皮膚表面に与えることが認められた。更に共焦点顕微鏡
を用いて上記の皮膚レプリカを画像化し、三次元解析を
した結果、皮膚のマイクロレリーフの密度の減少率にお
いて、BSA 含有水溶液と比較して高い減少率を示し、皮
膚の微小起伏 (マイクロレリーフ) を減少させ、皮膚を
平滑化することにより皮膚がより滑らかになることが明
らかとなった。これらの効果は BSA 含有水溶液或いは
クリームと比較しても同等以上であることが実証され、
斯くて本発明を完成するに至ったのである。
Therefore, an aqueous solution and a cream containing the above-mentioned extract mixture were prepared, and various tests were conducted using healthy volunteers to examine the effect of the extract mixture on skin. As a result, all volunteers answered that the aqueous solution containing this extract had a better skin tightening effect than the aqueous solution containing bovine serum albumin (BSA). In addition, when a skin replica before and after application was prepared and the skin surface was analyzed using a scanning electron microscope, the cream of the present invention had a reduced wrinkle depth compared to before application, and had a smoother appearance. To the skin surface. Furthermore, the above skin replica was imaged using a confocal microscope and subjected to three-dimensional analysis.As a result, the reduction rate of the density of the micro relief of the skin was higher than that of the aqueous solution containing BSA, and the micro relief of the skin was small. (Microrelief) was reduced and the skin was smoothed by smoothing the skin. These effects were demonstrated to be equal to or greater than those of an aqueous solution or cream containing BSA.
Thus, the present invention has been completed.

【0009】従って本発明による皮膚外用剤は豆科植物
の種子からの抽出物及び/又はシソ科植物の抽出物を有
効成分とし、豆科植物がシロバナルーピン (Lupinus al
busL.) であり、シソ科植物がタチジャコウソウ (Thymu
s vulgaris L.) であることを特徴としている。その抽
出物の含有量は剤型にも依存するが、効果及びコストを
勘案すると 0.1- 50.0 重量 % 程度が適当である。
Accordingly skin external preparation according to the invention the extract and / or an active ingredient extract of Labiatae plants from seeds of leguminous plants, leguminous plants white lupine (Lupinus al
bus L.), and the Labiatae plant is Thymu
s vulgaris L.). The content of the extract depends on the dosage form, but considering the effect and cost, it is appropriate to be about 0.1-50.0% by weight.

【0010】本発明による皮膚外用剤の剤型はクリーム
状、軟膏状、乳液状、ゲル状、フィルム状又は液状にす
ることができる。本発明による皮膚外用剤において「ク
リーム状」とは、水中油型又は油中水型に乳化されたも
のであって比較的粘性の高い状態のものを指称し、この
剤は安全性が保証された無機や有機の顔料を含有してい
ることができる。「軟膏状」とは、水を殆ど含有してい
ない油性のワセリン様の状態のものを指称し、この剤は
安全性が保証された無機や有機の顔料を含有しているこ
とができる。「乳液状」とは、水中油型又は油中水型に
乳化されており、比較的粘性が低く流動性を示す状態の
ものを指称し、この剤は安全性が保証された無機や有機
の顔料を有していることができる。「ゲル状」とは、澄
明であって流動性を有する低粘性から流動性のない高粘
性の状態のものを指称する。「フィルム状」とは、基体
の上に上記の軟膏状物を薄い層状を呈するように塗布し
た状態のものを指称する。「液状」とは、澄明であって
粘性を殆ど有しない水に近い状態のものを指称する。上
記の各状態の皮膚外用剤であって、化粧品剤型として具
体的なものとしてはスキンクリーム、化粧乳液、化粧
水、ローション、液体ファンデーション、プレストパウ
ダー、口紅、リップグロス等を例示することができ、整
髪料型としてはシャンプー、リンス、トリートメント等
を例示することができる。医薬品剤型としてはクリー
ム、ワセリン軟膏、ゲル軟膏、パップ剤、乳剤、硬膏剤
等を挙げることができる。
[0010] The dosage form of the external preparation for skin according to the present invention can be cream, ointment, emulsion, gel, film or liquid. In the external preparation for skin according to the present invention, "creamy" refers to a substance which is emulsified in an oil-in-water type or a water-in-oil type and has a relatively high viscosity. And inorganic or organic pigments. The term “ointment” refers to an oily vaseline-like state containing almost no water, and this agent may contain an inorganic or organic pigment whose safety is guaranteed. "Emulsion" refers to those that are emulsified in oil-in-water or water-in-oil and have relatively low viscosity and show fluidity. It can have pigments. The term “gel-like” refers to a state of being clear and having low viscosity having fluidity to high viscosity having no fluidity. "Film-like" refers to a state in which the above-mentioned ointment is applied on a substrate so as to form a thin layer. “Liquid” refers to a state close to water that is clear and has little viscosity. Skin external preparations in each of the above states, specific examples of cosmetic dosage forms include skin creams, cosmetic emulsions, lotions, lotions, liquid foundations, pressed powders, lipsticks, lip glosses, and the like. Examples of the hair styling type include shampoo, rinse and treatment. Examples of the pharmaceutical dosage form include cream, petrolatum ointment, gel ointment, poultice, emulsion, plaster and the like.

【0011】本発明の皮膚外用剤は、当然のことなが
ら、他の生理活性物質を副成分として含有していること
ができる。この副成分である生理活性物質としては、従
来から用いられてきた抽出物に含有されている成分であ
り、本明細書の冒頭において述べた各種の燐脂質、ビタ
ミン類、アミノ酸類、蛋白質、アルブチン、コウジ酸、
胎盤エキス、血清アルブミン (例えば牛血清アルブミ
ン)、グリコサミノグリカン、ヒアルロン酸、コラーゲ
ン、エラスチン、ポリフェノール (例えばタンニン)、
フラボノイド等を挙げることができる。
The external preparation for skin of the present invention can, of course, contain other physiologically active substances as accessory components. The physiologically active substance which is a secondary component is a component contained in an extract conventionally used, and includes various phospholipids, vitamins, amino acids, proteins, arbutin described at the beginning of the present specification. , Kojic acid,
Placenta extract, serum albumin (for example, bovine serum albumin), glycosaminoglycan, hyaluronic acid, collagen, elastin, polyphenol (for example, tannin),
Flavonoids and the like can be mentioned.

【0012】[0012]

【実施例等】次に、製剤例及び試験例に関連して本発明
を更に詳細に且つ具体的に説明する。尚、後述の試験例
及び製剤例において使用されたシロバナルーピンの種子
及びタチジャコウソウからの抽出物混合物 (以下、本抽
出物と称する) の乾燥粉末の外観等は下記の通りであっ
た。 外 観 : 褐色の粉末 pH : 4.6 (4% 水溶液 ) 乾燥残分 : 88.50 (重量 %) 無機塩 : 11.50 全窒素 : 1.36 フラボノイド : 1.70 ポリフェノール: 2.90
The present invention will now be described in more detail with reference to Formulation Examples and Test Examples. The appearance and the like of the dried powder of the extract mixture of the extract of the white root lupine and the extract of St. John's wort (hereinafter referred to as the present extract) used in the test examples and preparation examples described below were as follows. Appearance: Brown powder pH: 4.6 (4% aqueous solution) Dry residue: 88.50 (% by weight) Inorganic salt: 11.50 Total nitrogen: 1.36 Flavonoid: 1.70 Polyphenol: 2.90

【0013】製剤例 1 (水性液剤の調製) 1000ml の共栓付きメスフラスコに本抽出物を 40g、精
製水約 500ml を加え、約 5 分 間撹拌することにより
本抽出物を溶解させた。本抽出物が完全に溶解したこと
を確認した後、精製水により 1000ml にメスアップし、
共栓をして再び充分に撹拌することにより水性液剤 (本
抽出物を 40g/l 含有) を得た。
Formulation Example 1 (Preparation of Aqueous Liquid Preparation) 40 g of the present extract and about 500 ml of purified water were added to a 1000 ml volumetric flask with a stopper, and the extract was dissolved by stirring for about 5 minutes. After confirming that this extract was completely dissolved, make up to 1000 ml with purified water.
The mixture was stoppered and thoroughly stirred again to obtain an aqueous solution (containing 40 g / l of the present extract).

【0014】 製剤例 1 (クリーム剤の調製) 成分グループ A: ポリオキシエチレン (6) ステアレートと、 POE (20) セチルエーテルと、 ステアリン酸グリセリルと、 POE (20) ステアリルエーテルとの混合物 12.00 (重量 %) 硬化ヒマシ油 2.00 ミリスチン酸オクチルドデシル 5.00 ポリデセン 5.00 シリコーン油 (100cs) 2.00 成分グループ B: ジメチルポリシロキサンと ジメチルポリシロキサノールとの混合物 2.00 本抽出物 4.00 防腐剤及び香料 適量 グループ A の諸成分を 75℃ に加熱し、撹拌しながら
75℃ に加熱した精製水(100 重量 %) を添加した。この
溶液を約 45℃ に冷却し、シリコーン油及び本抽出物を
添加した。完全に冷却した後、その他の成分を全て添加
し、次いで全体を充分に混練することによりクリーム剤
を得た。
Formulation Example 1 (Preparation of Cream) Ingredient Group A: Mixture of polyoxyethylene (6) stearate, POE (20) cetyl ether, glyceryl stearate, and POE (20) stearyl ether 00 (wt%) hydrogenated castor oil 2.00 octyldodecyl myristate 5.00 polydecene 5.00 silicone oil (100cs) 2.00 Component group B: 2.00 mixture of dimethylpolysiloxane and dimethylpolysiloxanol Extract 4.00 Preservatives and fragrances qs Ingredients of Group A are heated to 75 ° C and stirred.
Purified water (100% by weight) heated to 75 ° C was added. The solution was cooled to about 45 ° C. and the silicone oil and the extract were added. After cooling completely, all other components were added, and the whole was thoroughly kneaded to obtain a cream.

【0015】試験例 1 (官能比較評価) 健常なボランティア被験者 10 名を対象とした。被験者
の額の左右 2 箇所を被験部位とし、左側に製剤例 1 に
より得られた水性液剤 (試験外用剤)を、右側に BSA 含
有 (3 重量 %) 水溶液 (対照外用剤)を1 滴滴下した
後、それぞれ 5cm2 で均一となるように塗り広げた。次
いで、両外用剤を塗布した額の皮膚の引き締まり具合を
各被験者に評価して貰ったところ、BSA 含有水溶液より
も製剤例 1 による水性液剤の方が皮膚の引き締まり具
合が良好である旨全員が表明した。
Test Example 1 (Sensory evaluation) Ten healthy volunteer subjects were tested . The left and right portions of the subject's forehead were used as test sites, and the aqueous liquid (external test preparation) obtained in Formulation Example 1 was dropped on the left side, and a BSA-containing (3 wt%) aqueous solution (control external preparation) was dropped on the right side Thereafter, each was spread to be uniform at 5 cm 2 . Next, when each subject evaluated the degree of tightening of the skin on the forehead to which both external preparations were applied, all the subjects that the aqueous liquid preparation of Formulation Example 1 had better skin tightening conditions than the aqueous solution containing BSA. Stated.

【0016】試験例 2 (走査型電子顕微鏡による観察) 健常なボランティア被験者 20 名を対象として、製剤例
2 により得られたクリーム剤の効果を調べた。まず初
めに、両目尻の 2 箇所の部位について皮膚レプリカを
作成した。その後、右目尻のレプリカ採取部位に製剤例
2 のクリーム剤 (試験外用剤)を 14mg(1cm2) 塗布し、
同様に左目尻のレプリカ採取部位に製剤例 2 のクリー
ム剤の抽出混合物に代えて同量の BSA を配合したクリ
ーム剤 (対照外用剤) を 14mg (1cm2) 塗布した。塗布6
0 分後に上記のレプリカ採取部位の皮膚レプリカを再度
作成し、得られた皮膚レプリカを走査型電子顕微鏡 (マ
ミヤ光機株式会社製の撮像システムに接続された日立株
式会社製の HITACHI S800 型) で観察し、210 倍で撮影
して皮膚レプリカの表面を解析した。その結果、本願発
明のクリーム剤は塗布前と比較して皺の深さが減少し、
BSA含有クリーム剤と比較しても更に滑らかな外観を皮
膚表面に与えることが認められた。
Test Example 2 (Observation by Scanning Electron Microscope) Formulation examples of 20 healthy volunteer subjects
The effect of the cream obtained in Example 2 was examined. First, skin replicas were made for two sites on both corners of the eyes. Then, apply the formulation to the replica collection site in the right eye corner
2 cream (external preparation) 14mg (1cm 2 ) Apply,
Similarly, 14 mg (1 cm 2 ) of a cream (external control) containing the same amount of BSA in place of the cream extract of Formulation Example 2 at the replica collection site at the left eye corner Applied. Application 6
0 minutes later, a skin replica of the above-described replica collection site is created again, and the obtained skin replica is scanned with a scanning electron microscope (HITACHI S800, manufactured by Hitachi, Ltd., connected to an imaging system, manufactured by Mamiya Kokki Co., Ltd.). Observed and photographed at 210x to analyze the surface of the skin replica. As a result, the cream of the present invention has a reduced wrinkle depth compared to before the application,
Compared to the BSA-containing cream, it was found that the skin had a smoother appearance.

【0017】試験例 3 (マイクロレリーフの密度の測
定) 45 - 50 歳の健常な女性ボランティア被験者 6 名を対
象とし、両目尻の 2 箇所の部位について皮膚レプリカ
を作成した。その後、右目尻のレプリカ採取部位に製剤
例 1 による水性液剤 (試験外用剤) を 1cm2 にわたり
8μl 塗布し、同様に左目尻 のレプリカ採取部位に BSA
(4 重量 %) 含有水溶液 (対照外用剤)を上記と同様に
塗布した。塗布 60 分経過後、再度上記のレプリカ採取
部位の皮膚レプリカを作成した。得られた皮膚レプリカ
を共焦点顕微鏡を用いて画像化し、その画像を三次元解
析することにより、皮膚のマイクロリレーフの減少率を
下記の式により算出した。 (微小皺の数/皺の総数) × 100 その結果、皮膚のマイクロリレーフの密度は、試験外用
剤を塗布した場合、塗布前と比較して 8% の減少が認め
られたのに対して、対照外用剤を塗布した場合は、塗布
前と比較して 5% の減少率であった。これにより本抽出
物は皮膚を平滑化する効果を有することが明らかとな
り、皮膚のマイクロレリーフを減少させるという点にお
いて、本抽出物は BSA と同等以上の効果があることが
明らかとなった。
Test Example 3 ( Determination of density of micro relief)
A) Skin replicas were prepared for two healthy female volunteers aged 45 to 50 years old at two sites in the outer corners of both eyes. After that, apply the aqueous liquid (external preparation for test) over 1 cm 2 to the replica collection site
Apply 8 μl, and apply BSA to the replica collection site
(4% by weight) -containing aqueous solution (control external preparation) was applied in the same manner as above. After 60 minutes from the application, a skin replica of the above-mentioned replica collection site was again prepared. The obtained skin replica was imaged using a confocal microscope, and the image was subjected to three-dimensional analysis, thereby calculating the skin microreflex reduction rate by the following equation. (Number of micro wrinkles / total number of wrinkles) × 100 As a result, the density of the microreflex on the skin was reduced by 8% when the external preparation was applied, compared to before the application, When the control external preparation was applied, the reduction rate was 5% compared to before the application. This revealed that the extract had an effect of smoothing the skin, and that the extract had an effect equal to or higher than that of BSA in reducing the microrelief of the skin.

【0018】[0018]

【発明の効果】本発明による皮膚外用剤は皮膚を引き締
め、且つ皮膚の皺の深さを減少させ、更に皮膚の微小起
伏 (マイクロレリーフ) を減少させて皮膚を平滑化させ
る。これらの効果は BSA を含有する水溶液或いはクリ
ームと比較しても同等以上である。
The external preparation for skin according to the present invention tightens the skin, reduces the depth of wrinkles in the skin, and further smoothes the skin by reducing the micro relief of the skin. These effects are equal to or greater than those of an aqueous solution or cream containing BSA.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 豆科植物であるシロバナルーピン (Lupi
nus albus L.) の種子からの抽出物及びシソ科植物であ
るタチジャコウソウ (Thymus vulgaris L.)の抽出物を
主たる有効成分として含有していることを特徴とする、
皮膚外用剤。
Is a method according to claim 1] leguminous plant white lupine (Lupi
nus albus L.) and an extract of Thymus vulgaris L., which is a Labiatae plant, as the main active ingredients,
External preparation for skin.
【請求項2】 剤型がクリーム状、軟膏状、乳液状、ゲ
ル状、フィルム状又は液状であることを特徴とする請求
項 1 に記載の皮膚外用剤。
2. The external preparation for skin according to claim 1, wherein the dosage form is cream, ointment, emulsion, gel, film or liquid.
【請求項3】 両抽出物の含有量が 0.1 - 50.0 重量 %
であることを特徴とする、請求項 1 又は 2 に記載の
皮膚外用剤。
3. The content of both extracts is 0.1-50.0% by weight
3. The external preparation for skin according to claim 1 or 2, wherein:
JP8164196A 1996-06-25 1996-06-25 Skin lotion Pending JPH107518A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8164196A JPH107518A (en) 1996-06-25 1996-06-25 Skin lotion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8164196A JPH107518A (en) 1996-06-25 1996-06-25 Skin lotion

Publications (1)

Publication Number Publication Date
JPH107518A true JPH107518A (en) 1998-01-13

Family

ID=15788512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8164196A Pending JPH107518A (en) 1996-06-25 1996-06-25 Skin lotion

Country Status (1)

Country Link
JP (1) JPH107518A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002265343A (en) * 2001-03-07 2002-09-18 Ichimaru Pharcos Co Ltd Cosmetic composition
FR2834638A1 (en) * 2002-01-11 2003-07-18 Medix Lab Topically applied dermatological or cosmetic composition, useful e.g. for promoting skin regeneration or treating edema, comprises flavonoid, lupin peptide extract and vegetable oil
US7029713B2 (en) 1999-04-19 2006-04-18 Laboratoires Pharmascience Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same
FR2944703A1 (en) * 2009-04-22 2010-10-29 Clarins Lab Cosmetic or dermatological composition, useful to delay or to fight against skin aging and/or the appearance of signs of skin aging e.g. wrinkles, fine lines and sagging skin, comprises an extract of Thymus citriodorus

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029713B2 (en) 1999-04-19 2006-04-18 Laboratoires Pharmascience Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same
US7638149B2 (en) 1999-04-19 2009-12-29 Laboratoires Expanscience Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
JP2002265343A (en) * 2001-03-07 2002-09-18 Ichimaru Pharcos Co Ltd Cosmetic composition
FR2834638A1 (en) * 2002-01-11 2003-07-18 Medix Lab Topically applied dermatological or cosmetic composition, useful e.g. for promoting skin regeneration or treating edema, comprises flavonoid, lupin peptide extract and vegetable oil
FR2944703A1 (en) * 2009-04-22 2010-10-29 Clarins Lab Cosmetic or dermatological composition, useful to delay or to fight against skin aging and/or the appearance of signs of skin aging e.g. wrinkles, fine lines and sagging skin, comprises an extract of Thymus citriodorus

Similar Documents

Publication Publication Date Title
US5476651A (en) Cosmetic or pharmaceutical composition, especially dermatological composition, intended for promoting the pigmentation of the skin or hair, containing an extract of cyperus, and the process for its manufacture
CN109937031B (en) Kangaroo claw extract for cosmetic use
JP2935518B2 (en) Hydration incorporating the extract of sapilla herbs or at least one component of this extract, and in particular a dermatological composition consisting of an antiallergic, antiinflammatory, antiaging composition, a cosmetic or pharmaceutical composition Compositions based on lipid lamellar phases or liposomes
US5591437A (en) Cosmetic or pharmeceutical composition containing a black horehound extract
KR100955389B1 (en) Cosmetic composition for pore-minimizing and inhibition of sebum secretion containing natural materials
US5653983A (en) Compositions for the pigmentation of the skin or of the hair containing an extract of Marrubium vulgare, the process for it's manufacture and it's
CN110022850B (en) Composition comprising truffle extract and neohesperidin dihydrochalcone
US7883691B2 (en) Cosmetic composition comprising camel milk or components thereof
KR101913808B1 (en) Cosmetic composition comprising dry flower for skin moisture
KR102083294B1 (en) A composition for skin reproduction containing extracts of abeliophyllum distichum and extract thereof having skin reproduction effect
KR102286908B1 (en) Skin cream cosmetic composition containing natural extract compound
JP2011207769A (en) Cosmetic and skin care preparation for external use
KR20020040669A (en) Agents improving skin barrier function
JP2001039848A (en) Skin lotion
KR102368903B1 (en) A composition for increasing the thickness of eyelashes, eyebrows and hair and promoting growth
JPH107518A (en) Skin lotion
JP2005298503A (en) Moisture-retention cosmetic composition containing pulverized polygonatum offcinale
KR102498980B1 (en) manufacturing method of a cosmetic composition for whitening containing peony extract and cosmetic composition for whitening containing peony extract prepared thereby
KR100667182B1 (en) Cosmetics for improvement xeroderma containing badger oil
KR102286909B1 (en) A serum-type cosmetic composition containing a natural extract compound
JP2000109417A (en) Cosmetic for improving somber color
KR102071600B1 (en) Cream composition manufacturing method for preventing of sensitive-skin and skin-trouble
CN115996702A (en) Silybum oil for enhancing skin barrier function
JPH09227397A (en) Preparation for external use for skin
KR101667308B1 (en) Anti-wrinkle cosmetic composition containing timosaponin, hyaluronic acid, collagen, calendula flower extract

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041004

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050228